| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.46▲ | 3.45▲ | 3.45▲ | 3.41▲ | 3.76▼ |
| MA10 | 3.48▲ | 3.45▲ | 3.44▲ | 3.37▲ | 4.50▼ |
| MA20 | 3.46▲ | 3.44▲ | 3.43▲ | 3.83▼ | 4.67▼ |
| MA50 | 3.44▲ | 3.38▲ | 3.37▲ | 4.69▼ | 7.78▼ |
| MA100 | 3.38▲ | 3.44▲ | 3.63▼ | 4.99▼ | 45.79▼ |
| MA200 | 3.44▲ | 4.01▼ | 4.47▼ | 7.00▼ | 68.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.002▲ | 0.005▲ | 0.019▲ | 0.503▲ |
| RSI | 54.875▲ | 55.513▲ | 55.148▲ | 38.302▼ | 30.660▼ |
| STOCH | 40.278 | 46.007 | 57.292 | 36.557 | 11.775▼ |
| WILL %R | -33.333 | -25.000▲ | -25.000▲ | -63.429 | -88.982▼ |
| CCI | 43.295 | 111.557▲ | 99.303 | -3.756 | -127.150▼ |
|
Thursday, November 06, 2025 05:16 AM
A replay of the corporate presentation will be available on the Events section of the company’s Investor Relations website.
|
|
Monday, October 27, 2025 07:48 AM
Cellectar Biosciences (NASDAQ:CLRB) shares soared 27% after the company received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration (FDA) for its iopofosine I 131 therapy ...
|
|
Monday, October 27, 2025 06:12 AM
Investing.com -- Cellectar Biosciences (NASDAQ:CLRB) stock surged 27% after the company received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for its iopofosine I 131 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 3.49 | 3.5596 | 3.41 | 3.54 | 55,668 |
| 07/11/25 | 3.40 | 3.50 | 3.31 | 3.39 | 70,828 |
| 06/11/25 | 3.33 | 3.59 | 3.26 | 3.43 | 132,962 |
| 05/11/25 | 3.39 | 3.39 | 3.25 | 3.34 | 40,835 |
| 04/11/25 | 3.26 | 3.50 | 3.171 | 3.35 | 126,579 |
| 03/11/25 | 3.43 | 3.43 | 3.20 | 3.30 | 52,793 |
| 31/10/25 | 3.26 | 3.41 | 3.25 | 3.39 | 62,264 |
| 30/10/25 | 3.29 | 3.46 | 3.25 | 3.26 | 58,008 |
| 29/10/25 | 3.26 | 3.53 | 3.25 | 3.35 | 143,954 |
| 28/10/25 | 3.61 | 3.61 | 3.31 | 3.31 | 252,749 |
|
|
||||
|
|
||||
|
|